The 3rd Annual Oncolytic Virotherapy Summit is the leading end-to-end industry focused gathering dedicated to bringing through clinic the next generation of immuno-oncolytic virotherapies for use in combinations.
The Oncolytic Virotherapy Summit sets the stage for oncolytic viruses to step into the limelight as the much-needed TME and immune modulating combination therapeutic of choice. NEW for 2017:
Attend this only industry-focused gathering to enhance the translation of innovative basic research into the next generation of clinically-relevant virotherapeutics. Register your interest to gain exclusive access to the early registration rates and confidential real-time updates on the agenda.
"This summit provided great talks. Topics were focused and inspiring. The oncolytic virotherapy community was enthusiastic and full of ideas." -
MIT | 2016 Attendee
“Extremely useful conference to meet other players in the modern OV development, which will make a change in how we are going to treat diseases like cancer.” - Boehringer Ingelheim | 2016 Attendee